A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma - Concepedia

Concepedia

Publication | Closed Access

A Novel Nitric Oxide Releasing Prostaglandin Analog, NCX 125, Reduces Intraocular Pressure in Rabbit, Dog, and Primate Models of Glaucoma

69

Citations

17

References

2010

Year

Valentina Borghi, Elena Bastia, Massimiliano Guzzetta, Valerio Chiroli, Carol B. Toris, Minerva Batugo, Samantha Carreiro, Wesley K. M. Chong, David C. Gale, David J. Kucera,

Journal of Ocular Pharmacology and Therapeutics

Abstract

NCX 125, a compound targeting 2 different mechanisms, is endowed with potent ocular hypotensive effects. This may lead to potential new perspectives in the treatment of patients at risk of glaucoma.

References

	Year	Citations

Page 1